Aortic Valve Stenosis

Anesthesiology Clinics

Volumn 27, Issue 3, 2009, Pages 519-532

  Zigelman, Charles Z ^a   Edelstein, Patti M ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Anesthesia; Aortic valve stenosis; Elderly; Geriatric; Management

Indexed keywords

ANTIBIOTIC AGENT; ATORVASTATIN; C REACTIVE PROTEIN; PLACEBO; ROSUVASTATIN;

ANESTHESIOLOGICAL TECHNIQUES; ANTIBIOTIC PROPHYLAXIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; BACTERIAL ENDOCARDITIS; BICUSPID AORTIC VALVE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; HEART INDEX; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MURMUR; HUMAN; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; SEX DIFFERENCE; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ANESTHESIA; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; RETINAL DETACHMENT;

EID: 70349755612     PISSN: 19322275     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anclin.2009.07.012     Document Type: Review

References (55)

1. Otto C.M., and Bonow R.O. Valvular heart disease. In: Libby P., Bonow R.O., and Mann D.L. (Eds). Braunwald's heart disease: a textbook of cardiovascular medicine. 8th edition (2007), WB Saunders, Philadelphia 1625-1633
2. Carabello B.A. Aortic stenosis. N Engl J Med 346 9 (2002) 677-682
3. Stephan P.J., Henry III C.H., Hebeler Jr. R.F., et al. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol 79 (1997) 166-172
4. Rajamannan N.M., and Otto C.M. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation 110 (2004) 1180-1182
5. Aronow W.S., Ahn C., and Kronzon I. Comparison of echocardiographic abnormalities in African-American, Hispanic and white men and women aged >60 years. Am J Cardiol 87 (2001) 1131-1133
6. Grimard B.H., and Larson J.M. Aortic stenosis: diagnosis and treatment. Am Fam Physician 78 6 (2008) 717-724
7. Grossman W., Jones D., and McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56 (1975) 56-64
8. Aranow W.S. Heart disease and aging. Med Clin North Am 90 (2006) 849-862
9. Freeman R.V., and Otto C.M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression and treatment strategies. Circulation 111 (2005) 3316-3326
10. Lewin M.B., and Otto C.M. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation 111 7 (2005) 832-834
11. Faggiano P., Antonini-Canterin F., Erlicher A., et al. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol 91 (2003) 99-101
12. Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352 (2005) 2389-2397
13. Rosenhek R., Rader F., Loho N., et al. Statins but not angiotensin converting enzyme inhibitors delay progression of aortic stenosis. Circulation 110 (2004) 1291-1295
14. Antonini-Canterin F., Hirsu M., Popescu B.A., et al. Stage related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol 102 (2008) 738-742
15. Dichtl W., Alber H.F., Feuchtner G.M., et al. Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). Am J Cardiol 102 (2008) 743-748
16. Fox C.S., Guo C.Y., Larson M.G., et al. Relations of inflammation and novel risk factors to valvular calcification. Am J Cardiol 97 (2006) 1502-1505
17. Imai K., Okura H., Kume T., et al. C-reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis. Am Heart J 156 (2008) 713-718
18. Sanchez P.L., Santos J.L., Kaski J.C., et al. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 97 (2006) 90-93
19. Pedersen T.R. Intensive lipid-lowering therapy for patients with aortic stenosis. Am J Cardiol 102 (2008) 1571-1576
20. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with valvular heart disease). Circulation 114 (2006) e84-e231
21. Friedrich A.D., and Shekar P.S. Interrogation of the aortic valve. Crit Care Med 35 8 Suppl (2007) S365-S371
22. Silvestry F.E., Kerber R.E., Brook M.M., et al. Echocardiography-guided interventions. J Am Soc Echocardiogr 22 (2009) 213-231
23. Johnson M.A., Moss R.R., and Munt B. Determining aortic stenosis severity: what to do when measuring left ventricular outflow tract diameter is difficult. J Am Soc Echocardiogr 22 (2009) 452-453
24. Khot U.N., Novaro G.M., Popovic Z.B., et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348 (2003) 1756-1763
25. Munt B., Legget M.E., Kraft C.D., et al. Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome. Am Heart J 137 (1999) 298-306
26. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343 (2000) 611-617
27. Kume T., Kawamoto T., Akasaka T., et al. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J Am Soc Echocardiogr 19 (2006) 914-918
28. Pellikka P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111 (2005) 3290-3295
29. Kume T., Kawamoto T., Okura H., et al. Rapid progression of mild to moderate aortic stenosis in patients older than 80 years. J Am Soc Echocardiogr 20 (2007) 1243-1246
30. Barasch E., Gottdiener J.S., Marino-Larsen E.K., et al. Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). Am J Cardiol 97 (2006) 1281-1286
31. Aronow W.S., Ahn C., Kronzon I., et al. Association of coronary risk factors and use of with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 88 (2001) 693-695
32. Bellamy M.F., Pellikka P.A., Klarich K.W., et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 40 (2002) 1723-1730
33. Moura L.M., Ramos S.F., Zamorano J.L., et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49 5 (2007) 554-561
34. Galante A., Pietroiusti A., Vellini M., et al. C-reactive protein is increased in patients with degenerative aortic valve stenosis. J Am Coll Cardiol 38 (2001) 1078-1082
35. Otto C.M. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 47 11 (2006) 2141-2151
36. Ambler G., Omar R.Z., Royston P., et al. Generic, simple risk stratification model for heart valve surgery. Circulation 112 (2005) 224-231
37. Roberts W.C., Ko J.M., Garner W.L., et al. Valve structure and survival in octogenarians having aortic valve replacement for aortic stenosis (± aortic regurgitation) with versus without coronary artery bypass grafting at a single US medical center (1993-2005). Am J Cardiol 100 (2007) 489-495
38. Roberts W.C., Ko J.M., and Matter G.J. Aortic valve replacement for aortic stenosis in nonagenarians. Am J Cardiol 98 (2006) 1251-1253
39. Iwahashi N., Nakatani S., Kanzaki H., et al. Acute improvement in myocardial function assessed by myocardial strain and strain rate after aortic valve replacement for aortic stenosis. J Am Soc Echocardiogr 19 (2006) 1238-1244
40. Rajappan K., Rimoldi O.E., Dutka D.P., et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 105 (2002) 470-476
41. Rajappan K., Rimoldi O.E., Camici P.G., et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 107 25 (2003) 3170-3175
42. Strotmann J.M., Lengenfelder B., Blondelot J., et al. Functional differences of left ventricular hypertrophy induced by either arterial hypertension or aortic valve stenosis. Am J Cardiol 101 (2008) 1493-1497
43. Unger P., Plein D., Van Camp G., et al. Effects of valve replacement for aortic stenosis on mitral regurgitation. Am J Cardiol 102 (2008) 1378-1382
44. Nemes A., Galema T.W., Geleijnse M.L., et al. Aortic valve replacement is associated with improved aortic distensibility at long term follow-up. Am Heart J 153 (2007) 147-151
45. Cheung A., and Ree R. Transcatheter aortic valve replacement. Anesthesiol Clin 26 (2008) 465-479
46. Shook D.C., and Savage R.M. Anesthesia in the cardiac catheterization laboratory and electrophysiology laboratory. Anesthesiol Clin 27 (2009) 47-56
47. Chiam P.T., and Ruiz C.E. Percutaneous transcatheter aortic valve implantation: evolution of the technology. Am Heart J 157 (2009) 229-242
48. Rodes-Cabau J., Dumont E., LaRochelliere R., et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 102 (2008) 1240-1246
49. Kertai M.D., Bountioukos M., Boersma E., et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 116 (2004) 8-13
50. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for non cardiac surgery). Circulation 116 (2007) 1971-1996
51. Mauck K.F., Manjarrez E.C., and Cohn S.L. Perioperative cardiac evaluation: assessment, risk reduction, and complication management. Clin Geriatr Med 24 (2008) 585-605
52. Porembka D.T. Importance of transesophageal echocardiography in the critically ill and injured patient. Crit Care Med 35 8 Suppl (2007) S414-S430
53. Nakamura K. Successful anesthetic management of two high-risk elderly patients using propofol-remifentanil. Masui 57 4 (2008) 479-482
54. Bagri A.S., Rico A., and Ruiz J.G. Evaluation and management of the elderly patient at risk for postoperative delirium. Clin Geriatr Med 24 (2008) 667-686
55. Ho M.C., Beathe J.C., and Sharrock N.E. Hypotensive epidural anesthesia in patients with aortic stenosis undergoing total hip replacement. Reg Anesth Pain Med 33 (2008) 129-133